IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in IGC Pharma, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +3 vs. Q1 2025
- Shares held
- 3.04M
- +178.4K (+6.2%) vs. Q1 2025
- Total value
- $929.4K
- +$114.5K (+14.0%) vs. Q1 2025
- New holders
- 5
- 6 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.41M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $814.9K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $943.4K |
| Q4 2023 | 25 | $691.3K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $3.97M |
| Q4 2021 | 29 | $6.07M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 612 | $0 | 0.00% | −100−14.0% | Reduced |
| Evermay Wealth Management LLC | 30 | $10 | 0.00% | 00.0% | Unchanged |
| DHJJ Financial Advisors, Ltd. | 80 | $25 | 0.00% | 00.0% | Unchanged |
| Hurley Capital, LLC | 100 | $31 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 108 | $33 | 0.00% | +103+2,060.0% | Added |
| Raymond James Financial Inc | 178 | $55 | 0.00% | +178 | New |
| CIBC Private Wealth Group, LLC | 655 | $200 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 727 | $223 | 0.00% | +123+20.4% | Added |
| Geneos Wealth Management Inc. | 3,000 | $930 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 7,187 | $2.20K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 11,834 | $3.62K | 0.00% | +11,834 | New |
| Tower Research Capital LLC (TRC) | 11,899 | $3.64K | 0.00% | −1,454−10.9% | Reduced |
| Jane Street Group, LLC | 13,316 | $4.08K | 0.00% | +13,316 | New |
| XTX Topco Ltd | 13,765 | $4.21K | 0.00% | −18,318−57.1% | Reduced |
| Morgan Stanley | 17,707 | $5.42K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 34,948 | $11.0K | 0.00% | +348+1.0% | Added |
| UBS Group AG | 36,308 | $11.1K | 0.00% | +36,307+3,630,700.0% | Added |
| Truist Financial Corp | 36,667 | $11.2K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 46,892 | $14.0K | 0.00% | +46,892 | New |
| Renaissance Technologies LLC | 55,025 | $16.8K | 0.00% | +55,025 | New |
| Goldman Sachs Group Inc | 65,541 | $20.1K | 0.00% | 00.0% | Unchanged |
| Dearborn Partners LLC | 84,401 | $25.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 113,407 | $34.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 160,207 | $49.0K | 0.00% | −5,100−3.1% | Reduced |
| Citadel Advisors LLC | 270,966 | $82.9K | 0.00% | +176,495+186.8% | Added |
| Vanguard Group Inc | 645,166 | $197.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 703,303 | $215.2K | 0.00% | +3,289+0.5% | Added |
| BlackRock, Inc. | 703,798 | $215.4K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −140,510−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |